Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline
Ott, E.; Lechner, H.
La Ricerca in Clinica e in Laboratorio 11(Suppl 1): 253-256
1981
ISSN/ISBN: 0390-5748 PMID: 7188113 Document Number: 179989
In 55 patients with acute or subacute CVD a beneficial but dose dependent effect of PO on human blood rheologic properties has been demonstrated, indicated by a lowering of blood viscosity, a decrease of fibrinogen concentration and inhibition of PA.
Document emailed within 1 workday
Related Documents
Weiss, D.J.; Geor, R.J.; Burger, K. 1996: Effects of pentoxifylline on hemorheologic alterations induced by incremental treadmill exercise in thoroughbreds American Journal of Veterinary Research 57(9): 1364-1368Anisimova, A.V.; Kolesnikova, T.I.; Anisimov, K.V.; Zhukotskiĭ, A.V. 2011: Prognostic value of hemorheologic and morphodensitometric parameters of blood cells for the progression of cerebrovascular insufficiency Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(11 Part 1): 46-52
Karim, M.R.; Ahmed, H.; Paul, R.K.; Chowdhury, M.; Alam, M.S.; Saha, A. 2016: Comparative Study between Pentoxifylline and Pioglitazone in the Treatment of Non-Alcoholic Fatty Liver Disease among Newly Detected Glucose Intolerant Patients Mymensingh Medical Journal: Mmj 25(2): 198-204
Clerc, M.; Doh-Egueli, D.; Chapuis, F.; Durin, A.; Bertrand, Y.; Souillet, G.; Philippe, N. 1989: Treatment of vaso-occlusive crisis of sickle-cell disease with pentoxifylline Pediatrie 44(7): 577-581
Thomson, G.J.; Thomson, S.; Todd, A.S.; Vohra, R.K.; Carr, M.H.; Walker, M.G. 1990: Combined intravenous and oral pentoxifylline in the treatment of peripheral vascular disease. A clinical trial International Angiology: a Journal of the International Union of Angiology 9(4): 266-270
Senanarong, V.; Poungvarin, N.; Phanthumchinda, K.; Thavichachart, N.; Chankrachang, S.; Praditsuwan, R.; Nidhinandana, S. 2009: Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients Journal of the Medical Association of Thailand 92(Suppl 2): S12-S18
Kiesewetter, H.; Jung, F. 1984: Hemorheologic therapy in peripheral arterial occlusive disease Fortschritte der Medizin 102(37): 921-924
Leschke, M.; Motz, W.; Strauer, B.E. 1986: Hemorheologic therapy applications in coronary heart disease Wiener Medizinische Wochenschrift 136(Special Issue): 17-24
Kovacević, M.S.; Racić, D.V.; Bumbasirević, L.; Kovacević, I.M.; Djajić, V. 1999: Arterial hypertension and acute cerebrovascular disease: treatment or no treatment? Srpski Arhiv Za Celokupno Lekarstvo 127(7-8): 266-269
Johnson, F.E.; Tolman, K.C.; Farr, S.A.; Davis, P.J.; Ludden, T.M.; Roy, T.K.; Raju, P.I. 1993: Serum levels of pentoxifylline and its metabolites in non-tumor-bearing mice after chronic oral pentoxifylline administration Journal of Medicine 24(2-3): 131-143
López-Liria, R.; Fernández-Alonso, M.; Vega-Ramírez, F.A.; Salido-Campos, M.Án.; Padilla-Góngora, D. 2014: Treatment and rehabilitation of dysphagia following cerebrovascular disease Revista de Neurologia 58(6): 259-267
Akarachkova, E.S.; Vershinina, S.V.; Kotova, O.V. 2012: Magnesium in the treatment and prevention of cerebrovascular disease Kardiologiia 52(9): 80-86
Al-Sumidaie, A.M.; Leinster, S.J.; Jenkins, S.A. 1987: Altered monocyte function in patients with benign breast disease Clinical and Experimental Immunology 67(1): 198-204
Tsuchihashi, T. 2004: Management of hypertension in patients with cerebrovascular disease Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 3): 460-464
Vlasova, I.V.; Vaizova, O.E.; Fedosova, N.N.; Vizilo, T.L. 2000: Endothelium-dependent vasodilation in patients with cerebrovascular disease Klinicheskaia Meditsina 78(11): 26-29
Tonin, P.; Da Col, C.; Battistin, L. 1985: Hemorheological parameters in patients with ischemic cerebrovascular disease La Ricerca in Clinica e in Laboratorio 15(Suppl 1): 313-316
Mansi, D.; Sinisi, L.; De Michele, G.; Di Geronimo, G.; Palma, V.; Brescia Morra, V.; Coppola, N.; Buscaino, G.A. 1988: Open trial of mesoglycan in the treatment of cerebrovascular ischemic disease Acta Neurologica 10(2): 108-112
Kikuta, K-ichiro.; Hashimoto, N. 2006: Current status and new horizon in surgical treatment of cerebrovascular disease Nihon Rinsho. Japanese Journal of Clinical Medicine 64 Suppl. 7: 482-488
Yamazaki, T.; Yanaka, K.; Aoki, T.; Matsuki, T.; Ono, F.; Fukuda, T.; Nose, T. 2000: Usefulness of Doppler echocardiography in patients with ischemic cerebrovascular disease No Shinkei Geka. Neurological Surgery 28(3): 233-236
Zaninović, K.; Plesko, N.; Poljaković, Z.; Klein-Pudar, M.; Pistotnik, M. 1992: Changes in coagulability of blood in patients with cerebrovascular disease in various meteorological situations Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 46(2): 85-89